Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products

To analyze the efficacy and safety of activated prothrombin complex concentrates (aPCC) and four-factor prothrombin complex concentrates (4F-PCC) to prevent hematoma expansion in patients taking apixaban or rivaroxaban with intracranial hemorrhage (ICH). In this multicenter, retrospective study, six...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, Renee, Chan, Alissa, Atallah, Steven, Derry, Katrina, Baje, Mark, Zimmermann, Lara L., Martin, Ryan, Groysman, Leonid, Stern-Nezer, Sara, Minokadeh, Anush, Nova, Alan, Huang, WanTing, Cang, William, Schomer, Kendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829230/
https://www.ncbi.nlm.nih.gov/pubmed/32500220
http://dx.doi.org/10.1007/s11239-020-02154-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829230/
https://www.ncbi.nlm.nih.gov/pubmed/32500220
http://dx.doi.org/10.1007/s11239-020-02154-z

Ejemplares similares